Genentech at ASHG 2026
Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website
Genentech at ASHG 2026 in Montréal: 3 presentations (3 posters).
| Organization | ASHG 2026 Attendance |
|---|---|
Genentech San Francisco, California | 1 Principal Bioinformatics Scientist · 1 Postdoctoral Fellow · 1 PhD Student · 1 Principal Fellow and Executive Director, Human Genetics, Research Biology |
Genentech is a biopharmaceutical company selling prescription medicines for patients with serious and life-threatening diseases. Its areas include oncology, neurology, and immunology.
| Poster Thu Oct 22 4:15 pm Defining shared components of genetic perturbation effects on cellular phenotypes and gene burden effects on human traits Rare variantsPhenome-wide associationSingle-cellRNA Poster Thu Oct 22 4:15 pm CONA detects disease-associated co-abundant cell neighborhoods using single-cell RNA-seq data Single-cellAlzheimer’s diseaseAutoimmune disorderRespiratory system Poster Fri Oct 23 2:30 pm Cell-type context improves GWAS trait enrichment in Perturb-seq programs but is captured by generic variant-to-gene methods Genome editing/CRISPRSingle-cellIdentification of disease genesRNA-seq |
Instantly find 20 buyers from Genentech
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction